Response to Commentary for 'Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials'

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL, USA.
² Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA.

Comment

Ahmed N Mahmoud et al. Eur Heart J. 2019.

. 2019 Sep 7;40(34):2924-2925.

doi: 10.1093/eurheartj/ehz224.

¹ Division of Cardiovascular Medicine, Department of Medicine, University of Florida, 1600 SW Archer Road, Gainesville, FL, USA.
² Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA.

No abstract available

Comment on

Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials.
Mahmoud AN, Gad MM, Elgendy AY, Elgendy IY, Bavry AA. Mahmoud AN, et al. Eur Heart J. 2019 Feb 14;40(7):607-617. doi: 10.1093/eurheartj/ehy813. Eur Heart J. 2019. PMID: 30561620
Aspirin for primary cardiovascular prevention: is there a need for risk stratification?
Aimo A, De Caterina R. Aimo A, et al. Eur Heart J. 2019 Sep 7;40(34):2922-2923. doi: 10.1093/eurheartj/ehz223. Eur Heart J. 2019. PMID: 31005987 No abstract available.